Novel Coronavirus (SARS-CoV-2/COVID-19)
The Health Resources and Services Administration Oct. 15 at 3 p.m. ET will host a webcast to provide additional information on the latest round of COVID-19 Provider Relief Funds.
The fifth in the Leadership Rounds series featured Dr. Estes talking with Dr. Kimberlydawn Wisdom, Senior Vice President of Community Health & Equity and Chief Wellness & Diversity Officer at Henry Ford Health System in Detroit and Michigan's First Surgeon General about health equity. This…
The Food and Drug Administration recommended that health care providers provide written or video step-by-step instructions, in addition to verbal instructions, to patients who are self-collecting anterior nares (nasal) samples for COVID-19 testing in a health care setting.
The Food and Drug Administration warned Battelle Memorial Institute that its respirator decontamination system does not comply with the requirement in its emergency use authorization to establish internal systems that provide for timely and effective identification, communication and evaluation of…
Learn about best practices and solutions that will improve health equity for mothers.
Emergency departments across the U.S. face enormous pressure during the pandemic. This story spotlights the ED team at University of Mississippi Medical Center in Jackson.
To meet the needs of parents with babies during the pandemic, pediatricians and staff at Monument Health Spearfish in South Dakota are coordinating donations of diapers.
The American Medical Association released for immediate use Current Procedural Terminology codes for reporting on medical claims two laboratory tests (87636 and 87637) that simultaneously detect the COVID-19 virus, influenza A/B and respiratory syncytial virus.
The National Institutes of Health’s Rapid Acceleration of Diagnostics initiative awarded $98.4 million in contracts to scale up and manufacture new COVID-19 testing technologies.
The Food and Drug Administration released guidance and a briefing document outlining the key data needed to support an emergency use authorization for a COVID-19 vaccine candidate and further explaining the EUA process.